Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.520
-0.074 (-2.85%)
At close: Mar 6, 2026, 4:00 PM EST
2.530
+0.010 (0.40%)
After-hours: Mar 6, 2026, 5:40 PM EST
Aytu BioPharma Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Aytu BioPharma stock have an average target of 9.33, with a low estimate of 7.00 and a high estimate of 13. The average target predicts an increase of 270.24% from the current stock price of 2.52.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 10, 2025.
Analyst Ratings
The average analyst rating for Aytu BioPharma stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $13 → $13 | Strong Buy | Maintains | $13 → $13 | +415.87% | Dec 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +177.78% | Sep 25, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +396.03% | Sep 25, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +217.46% | Jul 1, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +376.19% | Jun 30, 2025 |
Financial Forecast
Revenue This Year
57.63M
from 66.38M
Decreased by -13.19%
Revenue Next Year
83.05M
from 57.63M
Increased by 44.11%
EPS This Year
-1.68
from -2.16
EPS Next Year
-0.52
from -1.68
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 64.1M | 107.3M | |
| Avg | 57.6M | 83.0M | |
| Low | 51.6M | 68.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.5% | 86.2% | |
| Avg | -13.2% | 44.1% | |
| Low | -22.3% | 19.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.14 | 0.04 | |
| Avg | -1.68 | -0.52 | |
| Low | -2.17 | -1.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.